Full history for every metric is available with a Kvantra account
Key financial summary
Financials in GBP| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | £bn | 14.0 | 13.2 | 14.5 | 14.6 | 14.2 | 14.2 | 13.6 | 13.1 |
| Operating profit | £bn | 3.42 | 3.89 | ||||||
| Net profit | £bn | 1.19 | -0.03 | 2.33 | 1.64 | 1.43 | 3.18 | 2.88 | 2.17 |
| EPS reported | £ | 4.87 | 4.42 | ||||||
| Operating cashflow per share | £ | 3.52 | 3.25 | ||||||
| Capex per share | £ | 0.82 | 0.85 | ||||||
| FCF per share | £ | 2.70 | 2.39 | ||||||
| Free cash flow | £bn | 1.76 | 1.55 | ||||||
| Net debt | £bn | 6.20 | 9.29 | ||||||
| Book value equity | £bn | 7.75 | 5.67 | ||||||
| Book value per share | £ | 11.85 | 8.75 | ||||||
| Number of shares | m | 653.9 | 648.2 | ||||||
| DPS (TTM paid) | £ | 4.61 | 4.61 |
Financial summary
Financials in GBP| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | 12.32 | - | ||||||
| P/B LTM | x | 5.26 | 5.52 | ||||||
| P/S LTM | x | 2.87 | 2.29 | ||||||
| P/FCF LTM | x | 23.16 | 20.22 | ||||||
| EV/EBITDA LTM | x | 12.07 | 8.46 | ||||||
| EV/Sales LTM | x | 3.33 | 2.97 | ||||||
| Earnings Yield LTM | % | 8.12% | 9.03% | ||||||
| FCF Yield | % | 4.32% | 4.95% | ||||||
| Quality | |||||||||
| ROE | % | 41.08% | 42.87% | ||||||
| ROIC | % | 14.83% | 16.94% | ||||||
| Operating margin | % | 24.05% | 28.49% | ||||||
| Gross margin | % | 59.77% | 59.48% | ||||||
| FCF/Sales | % | 12.40% | 11.35% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | +139.90% | +298.20% | ||||||
| Sales Growth YoY | % | +0.25% | -2.49% | ||||||
| Net Income Growth YoY | % | +123.14% | +131.56% | ||||||
| FCF Growth | % | -20.57% | -13.24% | ||||||
| Operating Profit Growth | % | +40.87% | +73.05% | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 3.44% | 8.99% | ||||||
| Dividend Growth | % | +118.75% | - | ||||||
| Payout Ratio | % | 44.06% | 44.09% | ||||||
| FCF/Debt | x | 0.21 | 0.15 | ||||||
| Net Debt/EBITDA | x | 1.65 | 1.94 | ||||||
| EBIT/Net interest | x | 7.94 | 8.75 | ||||||
| Net debt/market cap | % | 15.21% | 29.69% | ||||||
| Net debt/Equity | x | 0.80 | 1.64 | ||||||
| Gross debt/equity | x | 1.09 | 1.79 | ||||||
ETFs that hold Reckitt Benckiser Group
| Fund | Ticker | Position# | Weight |
|---|---|---|---|
| Brandes International ETF | BINV | 10 | 1.95% |
| iShares MSCI Europe Consumer Staples Sector UCITS ETF | ESIS.DE | 7 | 3.75% |
| iShares STOXX Europe 600 Personal & Household Goods UCITS ETF (DE) | EXH7.DE | 7 | 5.05% |
| Elevation Series Trust - Polen International Dividend Income ETF | IDVZ | 2 | 3.83% |
| Amundi MSCI UK IMI SRI Climate Paris Aligned UCITS ETF DR - GBP (C) | FTSE.PA | 6 | 4.15% |
| State Street SPDR S&P UK Dividend Aristocrats UCITS ETF (Dist) | UKDV.L | 7 | 3.68% |
| VanEck Morningstar Global Wide Moat UCITS ETF | GOAT.L | 3 | 2.07% |
| State Street SPDR MSCI Europe Consumer Staples UCITS ETF | CSTP.L | 7 | 3.73% |
| Oakmark International Large Cap ETF | OAKI | 10 | 2.90% |
| Xtrackers MSCI Europe Consumer Staples Screened UCITS ETF 1C | DXSK.DE | 7 | 3.76% |
Funds with Reckitt Benckiser Group among their ten largest holdings, largest fund first.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Reckitt Benckiser Group Plc engages in the manufacture and trade of consumer brand products including Air Wick, Calgon, Cillit Bang, Clearasil, Dettol, Durex, Enfamil, Finish, Gaviscon, Harpic, Lysol, Mortein, Mucinex, Nurofen, Nutramigen, Strepsils, Vanish, Veet, and Woolite. It operates through the following segments: Hygiene, Health, and Nutrition. The company was founded by Isaac Reckitt in 1840 and is headquartered in Slough, the United Kingdom.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Reckitt Benckiser Group plc (RKT.L)
| Fund | Ticker | Position# | Weight |
|---|---|---|---|
| Brandes International ETF | BINV | 10 | 1.95% |
| iShares MSCI Europe Consumer Staples Sector UCITS ETF | ESIS.DE | 7 | 3.75% |
| iShares STOXX Europe 600 Personal & Household Goods UCITS ETF (DE) | EXH7.DE | 7 | 5.05% |
| Elevation Series Trust - Polen International Dividend Income ETF | IDVZ | 2 | 3.83% |
| Amundi MSCI UK IMI SRI Climate Paris Aligned UCITS ETF DR - GBP (C) | FTSE.PA | 6 | 4.15% |
| State Street SPDR S&P UK Dividend Aristocrats UCITS ETF (Dist) | UKDV.L | 7 | 3.68% |
| VanEck Morningstar Global Wide Moat UCITS ETF | GOAT.L | 3 | 2.07% |
| State Street SPDR MSCI Europe Consumer Staples UCITS ETF | CSTP.L | 7 | 3.73% |
| Oakmark International Large Cap ETF | OAKI | 10 | 2.90% |
| Xtrackers MSCI Europe Consumer Staples Screened UCITS ETF 1C | DXSK.DE | 7 | 3.76% |
Funds with Reckitt Benckiser Group among their ten largest holdings, largest fund first.
Based on consensus from external analysts. Not Kvantra's opinion.
Reckitt Benckiser Group Plc engages in the manufacture and trade of consumer brand products including Air Wick, Calgon, Cillit Bang, Clearasil, Dettol, Durex, Enfamil, Finish, Gaviscon, Harpic, Lysol, Mortein, Mucinex, Nurofen, Nutramigen, Strepsils, Vanish, Veet, and Woolite. It operates through the following segments: Hygiene, Health, and Nutrition. The company was founded by Isaac Reckitt in 1840 and is headquartered in Slough, the United Kingdom.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free